Evidence map›Paper›PMID 30995567›Full record

ReviewEuropean journal of medicinal chemistry2019

Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review.

Wan-Yin Fang, L Ravindar, K P Rakesh, H M Manukumar, C S Shantharam, Njud S Alharbi, Hua-Li Qin

Abstract readReview
In one paragraph

Review in European journal of medicinal chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Nitrosonium Ion-Catalyzed Oxidative Chlorination of Arenes.The Journal of organic chemistry · 2026
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Journal of the American Chemical Society · 2025
    Article
  16. Article
  17. Article
  18. Highlights on U.S. FDA-approved halogen-containing drugs in 2024.European journal of medicinal chemistry · 2025
    Review
  19. Article
  20. Halogenated 3-Nitro-2Antibiotics (Basel, Switzerland) · 2025
    Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wan-Yin FangSchool of Chemistry, Chemical Engineering and Life Science, School of Materials Science and Engineering, Wuhan University of Technology, 205 Luoshi Road, Wuhan, 430070, PR China.
L RavindarSchool of Chemistry, Chemical Engineering and Life Science, School of Materials Science and Engineering, Wuhan University of Technology, 205 Luoshi Road, Wuhan, 430070, PR China.
K P RakeshSchool of Chemistry, Chemical Engineering and Life Science, School of Materials Science and Engineering, Wuhan University of Technology, 205 Luoshi Road, Wuhan, 430070, PR China. Electronic address: rakeshasg@gmail.com.
H M ManukumarDepartment of Chemistry, Sri Jayachamarajendra College of Engineering, Mysuru, 570006, Karnataka, India.
C S ShantharamDepartment of Chemistry, Pooja Bhagavath Memorial Mahajana Education Centre, Mysuru, 570016, Karnataka, India.
Njud S AlharbiBiotechnology Research Group, Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
Hua-Li QinSchool of Chemistry, Chemical Engineering and Life Science, School of Materials Science and Engineering, Wuhan University of Technology, 205 Luoshi Road, Wuhan, 430070, PR China. Electronic address: qinhuali@whut.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At present more than 250 FDA approved chlorine containing drugs were available in the market and many pharmaceutically important drug candidates in pre-clinical trials. Thus, it is quite obvious to expect that in coming decades there will be an even greater number of new chlorine-containing pharmaceuticals in market. Chlorinated compounds represent the family of compounds promising for use in medicinal chemistry. This review describes the recent advances in the synthesis of chlorine containing heterocyclic compounds as diverse biological agents and drugs in the pharmaceutical industries for the inspiration of the discovery and development of more potent and effective chlorinated drugs against numerous death-causing diseases.

Indexed as

Drug DiscoveryAnimalsAnti-Bacterial AgentsAntimalarialsAntineoplastic AgentsGlycoside Hydrolase InhibitorsHumansHydrocarbons, ChlorinatedMolecular StructureAnti-Bacterial AgentsAntimalarialsAntineoplastic AgentsGlycoside Hydrolase InhibitorsHydrocarbons, ChlorinatedBiological applicationsChlorinated compoundsSARSynthesis

Identifiers

PMID30995567
PMCPMC7111421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.